ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "prevention"

  • Abstract Number: 0248 • ACR Convergence 2024

    Recombinant Herpes Zoster Vaccine in a Large Cohort of Autoimmune Rheumatic Diseases Patients: An Interim Analysis of a Prospective Randomized Phase 4 Study

    Nadia Aikawa1, Ana Cristina Medeiros-Ribeiro2, Sandra Pasoto3, Leonard Kupa3, Luciana Seguro4, ANA PAULA ASSAD3, Eduardo Borba3, Carla Goncalves Schahin Saad4, Emily Figueiredo Neves Yuki3, Danieli Andrade5, Andrea Shimabuco4, Karina Bonfiglioli3, Diogo Domiciano3, Julio Moraes3, Samuel Shinjo4, Percival Sampaio-Barros4, Henrique Giardini3, Joao de Oliveira3, Isabele Antonelli3, Renata Pinheiro3, Thais Bonini3, Marta Lopes6, Clovis Silva7 and Eloisa Bonfa3, 1Rheumatology Division and Pediatric Rheumatology Unit, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil, 2Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Jose Dos Campos, Brazil, 3Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, São Paulo, SP, Brazil, 4Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, SP, Brazil, 5University of São Paulo, São Paulo, SP, Brazil, 6Infectious Disease Department, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, São Paulo, SP, Brazil, 7Rheumatology Division and Pediatric Rheumatology Unit, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, SP, Brazil

    Background/Purpose: Patients with autoimmune rheumatic diseases (ARDs) are at high risk of herpes zoster (HZ) due to their condition and treatment. The new recombinant vaccine…
  • Abstract Number: 1721 • ACR Convergence 2024

    Recombinant Zoster Vaccine Uptake in US Adults with Rheumatic Disease: A Mixed Methods Analysis

    Justin Gatwood1, Catherine McGuiness2, Marie Yasuda2, Chi-Chang Chen2, Vasudha Gupta3 and Nikita Stempniewicz1, 1GSK, Philadelphia, PA, 2IQVIA, Wayne, PA, 3IQVIA, Durham, NC

    Background/Purpose: Compared to the immunocompetent US population ≥50 years, adults with rheumatic diseases are at increased risk for herpes zoster (HZ). To address this risk,…
  • Abstract Number: 0249 • ACR Convergence 2024

    Real World Evidence on the Safety of the Adjuvanted Recombinant Zoster Vaccine in Patients with Rheumatic Diseases – Preliminary Results from a Prospective Multicenter Observational Greek Study

    Christos Koutsianas1, Anastasia Apanomeritaki2, Evgenia Mavrea1, Niki-Violeta Dimopoulou1, Maria Nitsa1, CHRISTINA TSALAPAKI1, Iro-Ioanna Giannakopoulou2 and Dimitrios Vassilopoulos1, 1Clinical Immunology-Rheumatology Unit, 2nd Department of Internal Medicine and Laboratory, National and Kapodistrian University of Athens, School of Medicine, Hippokration General Hospital, Athens, Greece, 2Rheumatology Clinic, General Hospital Asklepieio Voulas, Voula, Attiki, Greece

    Background/Purpose: Patients with rheumatic diseases (RD) are at increased risk for herpes zoster (HZ) due to disease -related aberrant immune response, comorbid conditions and anti-rheumatic…
  • Abstract Number: 1745 • ACR Convergence 2024

    Use of Statins and Its Association with Major Adverse Cardiovascular Outcomes with Tofacitinib versus TNF Inhibitors in a Risk-Enriched Population of Patients with Rheumatoid Arthritis

    Jon Giles1, christina Charles-Schoeman2, Maya H. Buch3, Maxime Dougados4, Zoltan Szekanecz5, Ted Mikuls6, Steven R Ytterberg7, Gary G Koch8, Kenneth Kwok9, Mary Jane Cadatal10, Sujatha Menon11, Yan Chen12, Annette M Diehl12, Jose L Rivas13, Arne Yndestad14 and Deepak L Bhatt15, 1Cedars Sinai Medical Center, Los Angeles, CA, 2UCLA Medical Center, Santa Monica, CA, 3Division of Musculoskeletal & Dermatological Sciences, University of Manchester, and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom, 4Université de Paris; Department of Rheumatology, Hôpital Cochin; Assistance Publique-Hôpitaux de Paris; and INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France, 5Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary, 6University of Nebraska Medical Center, Omaha, NE, 7Division of Rheumatology, Mayo Clinic, Rochester, MN, 8Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 9Pfizer Inc, New York, NY, 10Pfizer Inc, Manila, Philippines, 11Pfizer Inc, Groton, CT, 12Pfizer Inc, Collegeville, PA, 13Pfizer SLU, Madrid, Spain, 14Pfizer Inc, Oslo, Norway, 15Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY

    Background/Purpose: ORAL Surveillance (NCT02092467; a post-authorization safety study of tofacitinib 5 and 10 mg twice daily [BID] vs TNF inhibitors [TNFi]) found higher incidence of…
  • Abstract Number: 0250 • ACR Convergence 2024

    Effectiveness of Tuberculosis Preventive Treatment in Patients with Rheumatic Diseases: A Global Meta-analysis of Cohort Studies

    Beiming Wang1, Shi Chen2, Xiaoqing Liu3 and Lifan Zhang3, 1Medical Doctor Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 2Division of Infectious Diseases, Department of Internal medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 3Peking union medical college hospital, Beijing, China

    Background/Purpose: As patients with rheumatic diseases (RDs) growing into a large population globally, concerns continue exist regarding the potential development of tuberculosis (TB) in this…
  • Abstract Number: 1880 • ACR Convergence 2024

    Statewide Burden of Osteoarthritis in India and Its Trend from 1990-2021: A Benchmarking Analysis

    Rafael Sanchez-Dopazo,1, malay rathod2, Ashwinikumar Shandilya3, Janmay Vala4, Eva Kalra5, Tapan Giri6, Saif Syed7, Mohit Lakkimsetti8, Juhi Patel9, VISHRANT AMIN10 and Hardik Desai11, 1Larkin Community Hospital Palm Springs Campus, Hialeah, FL, 2Monmouth Medical Center, Rutgers University, Ewing, NJ, 3Rural Medical college. Pravara institute of medical sciences., Ahmednagar, India, 4Terna Medical College, Navi Mumbai, Maharashtra, India, 5Trident Medical Cente, Charleston, SC, 6BJ Medical College, Pune, Pune, Maharashtra, India, 7Royal college of Surgeons,Dublin,Ireland, Dublin, Dublin, Ireland, 8Mamata Medical College,Khammam, Khammam, Telangana, India, 9GMERS MEDICAL COLLEGE VALSAD, 382330, Gujarat, India, 10GMERS MEDICAL COLLEGE VALSAD, Ahmedabad, India, 11Gujarat Adani Institute of Medical Sciences, Bhuj, India

    Background/Purpose: Osteoarthritis (OA) imposes a significant health burden globally, with India experiencing substantial demographic and epidemiological changes over the past three decades. This study addresses…
  • Abstract Number: 0255 • ACR Convergence 2024

    “Rheum” to Improve: Have Patients Attending the Young Adult Systemic Erythematosus (YASLE) Clinic Received All Appropriate Vaccinations? A Quality Improvement Initiative

    Razan Al Yaarubi1, Amanda Steiman1 and Earl Silverman2, 1University of Toronto, Toronto, ON, Canada, 2Silverman, Toronto, ON, Canada

    Background/Purpose: Infections are a leading cause of morbidity and mortality in patients with childhood-onset systemic lupus erythematosus (cSLE). Vaccination is a powerful tool to prevent…
  • Abstract Number: 1884 • ACR Convergence 2024

    VIVA QI: Vaccination In Vasculitis: Applying a Quality Improvement Approach

    Stephen Williams, Stephanie Garner and Aurore Fifi-Mah, University of Calgary, Calgary, AB, Canada

    Background/Purpose: The vasculitides are rare but serious conditions that are characterized by the destructive inflammation of the blood vessels. Patients living with vasculitis are often considered…
  • Abstract Number: 0260 • ACR Convergence 2024

    National Survey on Patient’s Knowledge and Drivers of Human Papillomavirus (HPV) Vaccination in Immune-mediated Inflammatory Diseases (IMIDs)

    Tiphaine Goulenok1, Arthur Mageau2, Chrystelle Francois1, Eric HACHULLA3, Thomas Papo2 and Karim Sacré2, 1Assistance Publique Hôpitaux de Paris, Paris, France, 2Université Paris Cité, Paris, France, 3CHU Lille, Département de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), Lille, France., LILLE, France

    Background/Purpose: Persistent human papillomavirus (HPV) infection is the cause of cervical cancer. Patients with immune-mediated inflammatory diseases (IMIDs) exposed to immunosuppressive therapy are at increased risk…
  • Abstract Number: 1907 • ACR Convergence 2024

    Community-Engaged Curriculum Development Using Racial Justice and Biomedical Lenses to Address COVID-19 Vaccine Hesitancy in Black Individuals with Rheumatologic Conditions

    Eseosa Osaghae1, Greta Sirek2, Tonya Roberson3, Mia Chandler4, Ariel Childs5, Monica Crespo-Bosque6, Gina Curry7, Amar Dhand8, Mary Dollear9, Alice Eggleston10, Nnenna Ezeh2, Dieufort Fleurissaint11, Denice Garrett12, Gail Granville13, Muriel Jean-Jacques1, Elena Losina2, Holly Milaeger1, Lutfiyya Muhammad14, Mary Ann Nelson15, Chisa Nosamiefan16, Bisola Ojikutu17, Neil Pillai1, Marie Jacques Toussaint18, Mary Beth Son19, Ana Valle2, Jessica Williams20, Michael York21, Karen Mancera-Cuevas22, Candace Feldman2 and rosalind Ramsey-Goldman1, 1Northwestern University, Chicago, IL, 2Brigham and Women's Hospital, Boston, MA, 3Governors State University College of Health and Human Services, University Park, IL, 4Boston Children’s Hospital, Boston, MA, 5Vital CxNs, Boston, MA, 6Boston Medical Center, Boston, MA, 7University of Chicago Pritzker School of Medicine, Chicago, IL, 8Brigham and Women’s Hospital, Boston, MA, 9Lupus Society of Illinois, Chicago, IL, 10Alliance Chicago, Chicago, IL, 11True Alliance Center, Inc, Boston, MA, 12Action for Bridgeport Community Development, Inc., Bridgeport, CT, 13Women of Courage, Inc, Boston, MA, 14Northwestern Feinberg School of Medicine, Chicago, IL, 15Mission Hill Health Movement Inc, Roxbury, MA, 16The Labalaba Foundation for Lupus Awareness and Advocacy, South Weymouth, MA, 17Harvard Medical School, Brigham and Women’s Hospital, Boston Public Health Commission,, Boston, MA, 18True Alliance Center, Inc., Boston, MA, 19Boston Children's Hospital, Brookline, MA, 20Emory School of Medicine, Atlanta, GA, 21Boston University, Boston, MA, 22National Health Council, Washington, DC

    Background/Purpose: Despite the efficacy of COVID-19 vaccines and the benefits for individuals with rheumatic conditions, racial inequities in uptake persist. We initiated a trial that…
  • Abstract Number: 0310 • ACR Convergence 2024

    I-CARE Program: Interest of Multidisciplinary Systematic Screening Program for Comorbidities for Patients Suffering from Arthritis Rheumatoid DiseasE: A Real Life Study

    Amine Mouamnia, Armentieres Hospital Center, Armentieres, France

    Background/Purpose: Inflammatory and auto-immune disease are associated to comordities. Indeed, patients suffering from arthritis rheumatoid disease (ARD) such as rheumatoid arthritis (RA), polymyalgia rheumatica (PMR)…
  • Abstract Number: 1957 • ACR Convergence 2024

    Assessing Left Ventricular Hemodynamic Forces in Systemic Sclerosis Patients: Pilot Study

    Aïcha Kante1, Andreea Afana2, Damien Sène3, Valérie Bousson4, Trecy Goncalves5, Edouard Ballout5, Solenn Toupin5, Jean-Guillaume Dillinger6, William Bigot3, Valentin Pagis7, Karine Champion3, Ruxandra burlacu7, stephane mouly3, Patrick Henry6, Theo Pezel6 and Cloé Comarmond3, 1Department of internal medicine, Centre de Compétence Maladies Rares autoimmunes et inflammatoires, Université Paris Cité, Paris, Ile-de-France, France, 2Department of Cardiology, University of Medicine and Pharmacy Craiova, Craiova, Romania, 3Department of internal medicine, Centre de Compétence Maladies Rares autoimmunes et inflammatoires, Lariboisière Hospital, Université Paris Cité, Paris, Ile-de-France, France, 4Department of Radiology, Lariboisiere Hospital, (Assistance Publique des Hôpitaux de Paris, AP-HP), Paris, Ile-de-France, France, 5Department of Cardiology, Lariboisiere Hospital, (Assistance Publique des Hôpitaux de Paris, AP-HP), Paris, France, 6Department of Cardiology, Lariboisiere Hospital, (Assistance Publique des Hôpitaux de Paris, AP-HP), Paris, Ile-de-France, France, 7Department of internal medicine, Centre de Compétence Maladies Rares autoimmunes et inflammatoires, Lariboisière Hospital, Université Paris Cité, Paris, France

    Background/Purpose: Systemic sclerosis (SSc) is a connective tissue disease marked by inflammation, microvascular changes and fibrosis. Cardiac comorbidities are the leading cause of mortality. Early…
  • Abstract Number: 0417 • ACR Convergence 2024

    Contraception in Community Rheumatology Practices

    Megan Clowse1, Julie Chiesa2, Pamela Freeman3, Bansari Gujar4, Kelley Jones5, Richard Jones6, Ann Marslett7, Amanda Snyderman5 and Leah Zulig8, 1Duke University, Chapel Hill, NC, 2InfoDirectors, Durham, NC, 3Rheumatology Associates of Central Florida, Orlando, FL, 4Rheumatology Associates of Baltimore, Towson, MD, 5Duke University School of Medicine, Durham, 6Clinic for Rheumatic Diseases, Northport, AL, 7Rheumatology Associates of Baltimore, Baltimore, MD, 8Duke University School of Medicine, Durham, NC

    Background/Purpose: Most prior studies of contraception in women with rheumatic disease focused on academic centers. In this study of non-academic rheumatology practices, we sought to…
  • Abstract Number: 1958 • ACR Convergence 2024

    Hemodynamic Forces: A Novel Cardiac MRI Parameter to Assess Cardiac Involvement in Sarcoidosis Patients

    Aïcha Kante1, Andreea Afana2, Damien Sène3, Karine Champion3, Valentin Pagis4, William Bigot3, Véronique Delcey5, Amanda Lopes3, Abdellatif Tazi6, Blanca Amador Borrero4, Bruno Crestani7, Claire Baladi8, Valérie Bousson9, Trecy Goncalves10, Edouard Ballout10, Solenn Toupin10, stephane mouly3, Jean-Guillaume Dillinger11, Patrick Henry11, Theo Pezel11 and Cloé Comarmond3, 1Department of internal medicine, Centre de Compétence Maladies Rares autoimmunes et inflammatoires, Université Paris Cité, Paris, Ile-de-France, France, 2Department of Cardiology, University of Medicine and Pharmacy Craiova, Craiova, Romania, 3Department of internal medicine, Centre de Compétence Maladies Rares autoimmunes et inflammatoires, Lariboisière Hospital, Université Paris Cité, Paris, Ile-de-France, France, 4Department of internal medicine, Centre de Compétence Maladies Rares autoimmunes et inflammatoires, Lariboisière Hospital, Université Paris Cité, Paris, France, 5Department of Infectious diseases, Lariboisère University Hospital, Paris, Ile-de-France, France, 6National Reference Center for Histiocytoses, Department of Pulmonology, AP-HP, Saint-Louis Hospital, Paris, France, 7National Reference Center for Rare Pulmonary Diseases, Department of Pulmonology, AP-HP, Bichat Hospital, Paris, Ile-de-France, France, 8Université d’Angers, Department of Cardiology, University Hospital of Angers, Angers, France, 9Department of Radiology, Lariboisiere Hospital, (Assistance Publique des Hôpitaux de Paris, AP-HP), Paris, Ile-de-France, France, 10Department of Cardiology, Lariboisiere Hospital, (Assistance Publique des Hôpitaux de Paris, AP-HP), Paris, France, 11Department of Cardiology, Lariboisiere Hospital, (Assistance Publique des Hôpitaux de Paris, AP-HP), Paris, Ile-de-France, France

    Background/Purpose: Cardiac sarcoidosis (CS) is an underdiagnosed condition characterized by the formation of non-caseating granuloma in the myocardium, potentially leading to arrhythmia, acute heart failure,…
  • Abstract Number: 0446 • ACR Convergence 2024

    Rheum for Improvement: Contraception Counseling and Adherence in Patients with Lupus and Rheumatoid Arthritis on Teratogenic Medications

    Kathryn Kompa1 and Vasileios Kyttaris2, 1Beth Israel Deaconess Medical Center, Boston, MA, 2BIDMC, Boston, MA

    Background/Purpose: Methotrexate (MTX) and mycophenolate (MMF) are two common medications for both lupus (SLE) and rheumatoid arthritis (RA). Both medications are contraindicated in pregnancy, necessitating…
  • 1
  • 2
  • 3
  • …
  • 12
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology